×
About 845 results

ALLMedicine™ Strongyloidiasis Center

Research & Reviews  312 results

Strongyloides stercoralis prevalence in solid-organ and haematopoietic stem cell transp...
https://doi.org/10.1136/bmjopen-2021-057649
BMJ Open; Barkati S, Naeem F et. al.

Aug 2nd, 2022 - Strongyloides stercoralis is an intestinal helminth ubiquitous in tropical and subtropical regions worldwide. It persists in the human host for a lifetime as a result of autoinfection and if undetected and untreated, can lead to increased morbidit...

Evaluation of Strongyloides Awareness and Knowledge among Canadian Physicians Caring fo...
https://doi.org/10.4269/ajtmh.22-0109
The American Journal of Tropical Medicine and Hygiene; De l'Étoile-Morel S, Naeem F et. al.

Jul 28th, 2022 - In Canada, a substantial proportion of migrants come from strongyloidiasis-endemic regions. Systematic screening for Strongyloides is not performed in immunocompromised patients in whom this infection could be potentially fatal. We aim to assess t...

Clinical Performance of Real-Time Polymerase Chain Reaction for Strongyloides stercoral...
https://doi.org/10.4269/ajtmh.21-1289
The American Journal of Tropical Medicine and Hygiene; Swan C, Phan T et. al.

Jul 28th, 2022 - Strongyloides stercoralis is a nematode endemic to subtropical and tropical regions that may cause asymptomatic carriage, peripheral eosinophilia, cutaneous, gastrointestinal, and pulmonary disease, or hyperinfection syndrome. Conventional diagnos...

Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.
https://doi.org/10.1016/S1473-3099(22)00369-3
The Lancet. Infectious Diseases; Gandasegui J, Onwuchekwa C et. al.

Jul 20th, 2022 - In 2020, WHO recognised the importance of strongyloidiasis alongside soil-transmitted helminths (STH) in their 2021-30 roadmap, which aspires to target Strongyloides stercoralis with preventive chemotherapy by use of ivermectin. Combination treatm...

Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study
https://clinicaltrials.gov/ct2/show/NCT04999774

Jul 18th, 2022 - Aim and objectives The aim of this project is to provide fundamental information on the performance and applicability of diagnostic methods for the assessment of S. stercoralis infection to inform the forthcoming WHO global strongyloidiasis contro...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  6 results

Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study
https://clinicaltrials.gov/ct2/show/NCT04999774

Jul 18th, 2022 - Aim and objectives The aim of this project is to provide fundamental information on the performance and applicability of diagnostic methods for the assessment of S. stercoralis infection to inform the forthcoming WHO global strongyloidiasis contro...

Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms
https://clinicaltrials.gov/ct2/show/NCT04407507

May 21st, 2021 - In late 2019, an unidentified viral pneumonia was detected in Wuhan, China. Later, it was declared that it was pneumonia due to a new coronavirus. The World Health Organization (WHO) officially called it COVID-19 disease (Xie and Chen 2020). Iverm...

Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
https://clinicaltrials.gov/ct2/show/NCT04709848

Jan 14th, 2021 - Strongyloidiasis is a worm infection which affects more than 100 million people, mostly in Africa, Asia and Latin America. Infection can persist for decades, and usually causes mild symptoms. In some people with reduced immune systems (for example...

Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
https://clinicaltrials.gov/ct2/show/NCT01570504

Jun 14th, 2018 - Ivermectin is currently the best drug to cure strongyloidiasis, but the "standard" single dose of 200 mcg/kg is probably not enough to guarantee cure. As strongyloidiasis can be fatal in immunosuppressed patients, it is mandatory to define the opt...

Ivermectin Versus Albendazole for Chronic Strongyloidiasis
https://clinicaltrials.gov/ct2/show/NCT00765024

Sep 7th, 2017 - A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.

see more →

News  15 results

Ivermectin and COVID: Is a Microscopic Worm the Key?
https://www.medscape.com/viewarticle/970567

Mar 22nd, 2022 - This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine If you took a random sample of 100 people from around the world, ei...

Ivermectin Did Not Reduce COVID Hospitalizations, Study Shows
https://www.medscape.com/viewarticle/970728

Mar 22nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The anti-parasitic drug ivermectin does not reduce hospitalizations of people infected with COVID-19, according to a large study conducted in Cana...

FDA Warns Against Using Ivermectin to Treat COVID-19
https://www.medscape.com/viewarticle/947049

Mar 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The US Food and Drug Administration (FDA) has issued guidance warning consumers against using the antiparasitic drug ivermectin to treat or preven...

Petechial Rash on the Thighs in an Immunosuppressed Patient
https://www.mdedge.com/dermatology/article/223579/mixed-topics/petechial-rash-thighs-immunosuppressed-patient
Angie Y. Wan, BA, Melissa Piliang, MD

Jun 9th, 2020 - The Diagnosis: Disseminated Strongyloidiasis Strongyloidiasis is a parasitic infection caused by Strongyloides stercoralis. In the United States it is most prevalent in the Appalachian region.

Consider strongyloidiasis before giving oral steroids
https://www.mdedge.com/infectiousdisease/article/137867/infectious-diseases/consider-strongyloidiasis-giving-oral-steroids
Bianca Nogrady

May 9th, 2017 - SYDNEY – Think twice before prescribing oral steroids for patients who have urticarial dermatitis, diarrhea, and cough, especially if they have lived in or recently traveled to tropical areas, Ian McCrossin, MD, said at the annual meeting of the A.

see more →